openPR Logo

Press Releases by Category Health & Medicine

RSS-Newsfeed

Injectable Drug Delivery Evolving Rapidly as Protein Drugs for Chronic Condition …

(Amherst, NH) – As pharmaceutical companies struggle to position their products in the direct-to-consumer marketing era, the trend toward combining functionality and packaging in drug delivery systems is growing. Innovative drug delivery systems allow pharmaceutical companies to differentiate drug products from competitors. This is essential at a time when many patents are running out and competition among the manufacturers of generic medicines is increasing. The formulation of biologics is testing

A Ranking of Environmental Chemicals

How dangerous are environmental chemicals and what is their effect on human health? In a project funded by the Austrian Science Fund FWF, the pharmacist Daniela Schuster is currently developing a computer-based "early warning system" for potentially dangerous substances. In our daily lives we are exposed to a great variety of environmental chemicals found in cleaning substances, cosmetics, plastic products, textiles or food supplements. Many of these synthetic products leave

The Sixth International Drug-Drug Interaction (DDI) Workshop at Marbach Castle, …

Öhningen, Germany, May 04, 2015: At the moment more than 80 drug development and interaction experts participate at the sixth International Drug-Drug Interaction Workshop and they are discussing regulatory requirements and current scientific aspects on the preclinical and clinical investigation of drug-drug interactions. The overall objective of the Drug-Drug Interaction Workshop series at Marbach Castle is to improve and disseminate the scientific knowledge about drug-drug interactions (incl. food-drug and herb-drug interactions),

Adelphi University Center for Health Innovation Selected for a PCORI Pipeline to …

The Patient-Centered Outcomes Research Institute (PCORI) today announced the Adelphi University Center for Health Innovation was approved for funding for the Native American Health and Wellness: Reservation-Based Diabetes and Obesity Prevention project. The Patient-Centered Outcomes Research Institute (PCORI) accepted only 17 percent of Tier I project proposals through the community building "Pipeline to Proposal" Awards program, which enables patients, advocacy groups, clinicians, and others who are not usual candidates for

Effective EHS Management Plans and Solutions for GCC Construction Industry

4th Middle East OHS Strategy Forum taking place in Abu Dhabi on 5 -7 May 2015 will bring industry experts and solution providers to address issues related to construction industry. Despite the oil price uncertainties, GCC economies are enjoying a strong fiscal position. The major contributor is the GCC region's construction sector which has observed continued investment from private developers and government clients in new infrastructure and real estate projects. Contracts

Specialty Injectables Relying Increasingly on Autoinjectors for Delivery and Dif …

(Amherst, NH) – As injectables for chronic conditions have proliferated, devices that can be prefilled have become the primary device class for branded products. Until recently, the prefilled injection devices segment has been dominated by two major types - prefilled syringes and pen injectors, which combined for more than 80% of devices in this category on a unit basis in 2012. In the past three years, autoinjectors – pen-like devices that

Medical Device Validation Conference Back for Second Consecutive Year

The most popular event for validation professionals in the medical device and diagnostic space is back with presenters from leading companies and new topics on the agenda. The 2nd Annual Medical Device and Diagnostic Process Validation Conference will be held July 20-21, 2015 in Arlington, Virginia, offering a wide variety of networking and idea sharing opportunities with implementable takeaways. This year, topics will address a plethora of challenges that validation professionals

Q1 Productions to Host 4th Annual Patient Advocacy Conference This Summer

For the fourth consecutive year, Q1 Productions will host the annual Strengthening Patient Advocacy Relations Conference, July 23-24, 2015 in Philadelphia, Pennsylvania, offering a wide array of discussion and learning opportunities to patient advocacy professionals with new topics from some of the most influential leaders in the space. As the premier event for pharmaceutical and patient groups, the event will provide a platform for open floor discussion on the most top-of-mind

dinCloud Introduces Specialized Healthcare Cloud Services

Cloud Services Provider Enables Healthcare Industry with Expanded Security, Accessibility, and Disaster Recovery Capabilities LOS ANGELES, CA – April 15, 2015 – dinCloud, a cloud services provider that helps businesses rapidly migrate to the cloud through business provisioning, today announced cloud services specially developed and packaged for the healthcare industry. These services were designed to meet the growing needs of healthcare providers looking for a secure hosted solution with business

Brain Training Instead of Medication to Counter Insomnia

The ability to finally enjoy a good night’s sleep is something that can be learned. An Austrian Science Fund FWF project has investigated how this can best be learned and who responds best to such "brain training". Dark circles around the eyes, tired limbs, absent-mindedness – most people have experienced the effects on the body of a short night. "Roughly one-third of the Austrian population as a whole suffers from

Two New CME Modules Added to the European Obesity Initiative on epgonline.org

Today, two new modules have been added to the EACCME-accredited European Obesity Initiative Continuing Medical Education (CME) series on epgonline.org, the website for healthcare professionals. The modules are free to access and worth a combined total of 3 European CME credits (ECMECs). Globally, there are more than 1.9 billion overweight adults, of whom at least 600 million are clinically obese.1 Obesity is a complex condition associated with increased risk of

Adelphi University’s Award-Winning Exploring Critical Issues Will Discuss Concus …

Exploring Critical Issues, the award-winning televised series conceived and hosted by Adelphi University President Robert A. Scott, continues to bring expert panelists together to discuss important current topics. The latest edition will discuss concussions, a head injury resulting in temporary loss of brain function. It will air for two weeks, beginning on Sunday, April 19, 2015 at 10:00 PM. “Concussions are a major public health concern. They result in temporary loss

Every Nursery, School And Family Should Play Its Own ‘Face Picture Pairs’ Card G …

The Wellcome Trust’s science essay award for ‘Prosopagnosia - a Common Problem, Commonly Overlooked’ helped briefly direct public attention to the problem of ‘face blindness’, which far too many people are suffering from. Specialists recommend every family, nursery and school to test children for face perception disorders with a personalised picture pairs card game with faces of classmates or family. Cambridge. 26 March 2015. - Based on recent scientific reports, it

Brain Activity During Cardiac Arrest

All over the world, researchers are trying to solve an age-old mystery: What happens in the brain when the heart stops? With the support of the Austrian Science Fund FWF, medical experts from Vienna are participating in an international study that looks into memory processes during cardiac arrest. How do we learn languages, how do feelings arise and what happens while we sleep? State-of-the-art methods of brain research are able

Healthcare Executive Leadership Forum Registration Now Open

Executive leaders of hospitals, healthcare systems, academic medical centers, and more are invited to take part in the Healthcare Executive Leadership Forum. The forum will take place in Alexandria, Virginia on April 27-28, 2015 and will offer a plethora of sessions, panel discussions, case studies, and networking opportunities. The forum will offer a wide variety of perspectives from experienced leaders who have seen success in the latest ventures and solutions in

Avanti Senior Living Partners with Eldermark to Help Team Tailor Care to Each Re …

Avanti Senior Living, a revolutionary company that develops, operates and manages boutique-style senior living communities, and Eldermark, a nationwide software solutions provider for senior housing management, are leading the way with innovative technology in taking electronic healthcare records management to the next level. The two companies are preparing to launch an integrated electronic healthcare record-keeping system which will allow electronic healthcare records to be shared via a healthcare information exchange

New Topics, New Speakers on Agenda at Medical Device and Diagnostic Labeling Con …

The 2nd Semi-Annual Medical Device and Diagnostic Labeling Conference will be held April 30-May 1, 2015 in Arlington, Virginia, offering labeling and regulatory affairs executives an exclusive opportunity to discuss the latest compliancy and regulatory requirements enacted by the FDA, as well as both domestic and global practices. The conference, hosted by Q1 Productions, will offer sessions, panel discussions, and interactive small group workshops led by some of the

Multi - Defibrillator Tester for all types of shock waveforms

The GOSSEN METRAWATT, provider of test and measurement products, introduces the SECULIFE DFPRO, a new tester for testing defibrillators and transcutaneous pacemakers. The SECULIFE DFPRO can analyze all common types of shock waveforms, monophasic, biphasic and pulsed biphasic. The SECULIFE DFPRO Defibrillator Analyzer, thanks to the latest electronic technologies used precisely deliver consistent test results for all defibrillators, regardless of manufacturer or model. Whether you want to measure the

The sixth International Drug-Drug Interaction (DDI) Workshop at Marbach Castle, …

Gelnhausen, Germany, December 19, 2014: The faculty of the International DDI Workshop presents the programme of the DDI 2015 – 6th International Workshop on Regulatory Requirements and Current Scientific Aspects on the Preclinical and Clinical Investigation of Drug-Drug Interactions, which will take place from May 3rd to 5th 2015 at Marbach Castle, Germany. The overall objective of the Drug-Drug Interaction Workshop series at Marbach Castle is to improve and disseminate the scientific

New Speakers, More Small Group Interaction Planned for 6th Annual Medical Device …

The most popular meeting for sales training professionals is back for a sixth consecutive year with more than two dozen speakers, new discussion topics, and more interactive small group breakout sessions. The 6th Annual Medical Device & Diagnostic Sales Training and Development Conference will be held in Charlotte, North Carolina, March 30-31, 2015, offering executives from small, medium and large companies and opportunity to share ideas and take away best

Drugs Developed for Subcutaneous Injection Benefiting from the Trend to Patient …

(Amherst, NH) – As healthcare markets continue to evolve, drug developers and their supply chain partners are attempting to keep pace by addressing economic, market and therapeutic factors that increasingly revolve around how, when and where drugs are administered. This evolution is being driven by new and exciting options for patient care in the form of powerful drug therapies for treating diseases with improved outcomes and for treating diseases for

EGFR Kit of AmoyDx, China, Supplier to MoBiTec, Germany, Ranks Top in 2014 Lung …

The European Molecular Genetics Quality Network (EMQN) is an independent organization based in the UK that promotes improvement in the quality of genetic testing by ensuring that diagnostic molecular genetic laboratory test results are accurate, reliable, and comparable. Amoy Diagnostics, located in Xiamen, China, provides state-of-the-art molecular diagnostic products and services to healthcare providers, academic institutions, and pharmaceutical companies. The company has a rich portfolio of tests that focuses on detecting

Therapeutic Antibody Drugs Being Designed for Self-Administration as Developers …

(Amherst, NH) – The administration of therapeutic antibodies is becoming an increasingly important healthcare treatment option for a growing number diseases and indications having broad implications for patient health and well-being. But to fully exploit the value of this class of therapeutics in both human and commercial terms, developers must successfully navigate the inherent limitations of antibody storage and administration, moving away from antibody infusion and toward injection as a

New Topics, New Speakers On Agenda for 5th Annual Medical Device Clinical Traini …

For the fifth consecutive year, clinical training professionals will have the opportunity to share ideas and obtain in-depth insight on some of the biggest issues in the industry at the Medical Device Clinical Training and Education Conference, March 30-31, 2015 in Charlotte, North Carolina. This conference is the only meeting of its kind, and caters specifically to clinical education executives of small, medium, and large companies from all corners of

ECA’s Working Group “Visual Inspections” nominates Chair

Although the Pharmacopoeias provide some information relative to visual inspections of parenterals, there is no substantial GMP regulation – neither in the Europe nor in the US. As a result there are ongoing discussions with regard to issues like AQL testing, use of testing kits, qualification/validation/verification of automated systems and training of the manual visual inspection staff. For that reason the ECA Foundation established its “Visual Inspections” Working Group in

Precisely Off The Mark: Possible Cause Discovered For Failure of Targeted Liver …

The failure of experimental liver cancer therapies directed specifically against the EGFR protein is presumably the result of insufficiently specific patient selection. This is the conclusion that can be drawn from data that were obtained within the framework of a project carried out by an Austrian Science Fund FWF doctoral programme, and that have now been published in NATURE Cell Biology. The data prove that the tumour-promoting effect of EGFR

Regensburg patient for five years on a ventricular assist device

It was a special anniversary for Mr. Max. K from the Bavarian town Ortenburg: For five years now he is kept alive by the ventricular assist device (VAD) INCOR®. Within the University Hospital Regensburg Mr. K is the patient with the longest support time by this device. The patient’s story of the 54-year-old patient goes back a few years. After he had a strong flu in 2006, Max K.’s right heart

New Speakers, New Topics on 6th Annual EU Reimbursement and Market Access Confer …

For the sixth consecutive year, Q1 Productions is hosting the EU Device and Diagnostic Reimbursement and Market Access Conference, offering healthcare executives an opportunity to address the most up to date topics surrounding the reimbursement and market access space with some of the industry’s experts. The conference will be held February 23-24, 2015 in Frankfurt, Germany and will focus on maintaining improvement and advancing innovation in European markets. Attendees will explore

Electronics Capable of Sensing Trace VOCs and the Future of Patient Diagnostics

(Amherst, NH) – The continued evolution of microelectronics and advances in noise reduction and signal processing are paving the way toward sensing systems that can recognize trace levels of volatile organic compounds at the parts-per-billion level. By linking these devices to digital libraries and employing pattern recognition software, these devices have the potential to detect the presence of biomarkers in exhaled breath and the gaseous phase of bodily fluids to

UMS AG: Satisfactory Performance in Q3 2014

- Weak US dollar continues to influence revenues and earnings - Expenses for the sale of UMS DE, Inc. adversely affect earnings per share by 19 cents or EUR0.9 million Hamburg, November 13, 2014 - UMS United Medical Systems International AG (UMS/ ISIN DE0005493654) improved its revenues and earnings in the third quarter of fiscal year 2014. Against the backdrop of a challenging market environment, the company's performance is considered satisfactory. Group

ICD Code Converter Now Available

Clearwater, FL- EON Systems, Inc., the provider of The Digital Office™, a complete software suite for healthcare providers, is excited to announce the launch of its ICD Converter App. The company’s new product, which launched on October 31st, 2014, is available on all Android®, iPad® and iPhone® products. EON’s ICD Converter app features both ICD-9 to ICD-10 conversion and ICD-10 to ICD-9 conversion. In addition

New Session Topics, More Speakers on Agenda for 4th Annual Medical Communication …

The 4th Annual Medical Communications and the Dissemination of Healthcare Information Conference will be held February 26-27, 2015 in Boston, Massachusetts, providing attendees an opportunity to discuss the most updated guidelines and best practices within the industry. This year’s agenda offers exclusive insight to new regulations and rules, as well as perspective from editors and publishers on streamlining internal processes and mitigation strategies. This year’s event brings together executive leaders from

USM: Successful Closing of the Sale of United Medical Systems (DE), Inc.

Hamburg, November 11, 2014 - UMS United Medical Systems International AG (ISIN DE0005493654) has successfully consummated the sale of all shares in United Medical Systems (DE), Inc. to UMS Acquisition Holdings, Inc. (New State Capital Partners). The purchase price has been effectively transferred to the company's account today. About UMS AG UMS International AG is a provider of innovative healthcare delivery concepts in the growth segment of high-tech medicine. UMS pioneered the

Intradermal Drug Delivery Gaining Momentum as Technology and Benefits Converge

(Amherst, NH) – Evolution in drug delivery device design is changing the way a growing number of therapeutic substances are administered. This trend is being fostered by the desire by patients for more user friendly methods for self-medicating, and by the need for safer, more reliable drug products that improve compliance. For drugs capable of being administered across the skin, intradermal delivery is viewed as an approach that addresses these

Healthcare IT India Summit set for May 2015

Fleming Gulf Conferences will be hosting the Healthcare India Summit for the third consecutive year, offering participants networking opportunities and insights from industry experts. The conference will be held in Bengaluru on 7-8 May 2015. According to recent research by Frost and Sullivan, India's healthcare IT market is expected to triple to US$1.45 billion in 2018, from the US $381.3 million recorded in 2012. The report listed patient demographic

Stryker Europe Expands Its Deployment of SATO’s PJM RFID Solutions to Nordic Reg …

Tokyo, October 31, 2014 – SATO, a leader in barcode printing, labeling, and EPC/RFID solutions, and Altrax Group, a leader in traceability solutions for the healthcare environment, Bristol, UK, co-announced today that Medical device manufacturer Stryker Europe has adopted SATO’s PJM* RFID solutions in their Swedish distribution centre. Prior to the Nordic countries, Stryker Europe has introduced PJM RFID solutions at its main distribution centres in UK, France, Germany, Spain,

Urban Health and City Planning

Urban environments and the planning processes that shape them are strong determinants of public health. On Monday, November 3, join city planners and healthcare experts at the German Center for Research and Innovation (GCRI) in New York for a discussion on how to plan healthier cities for the future. NEW YORK (October 28, 2014) – By 2050, over two-thirds of the world’s population will live in cities, yet we have only

Head of Innovation for Bayer and The National Director for Patient and Informati …

Kemal Malik, Head of Innovation at Bayer, and Tim Kelsey, National Director for Patient and Information for NHS England are slated to keynote the upcoming 5th Annual Health 2.0 Europe conference on November 10-12 in London, UK. The international digital health conference will feature a wide variety of sessions on some of the most important topics in digital health including: • Medical R&D: How medicine continues to grow with Health 2.0

Meet aycan at Medica 2014 in November

aycan is going to present its print, post-processing and teleradiology DICOM PACS- solutions at the Medica exhibition 2014. The world’s largest medical exhibition, the Medica, will be held from 12th until 15th November in Düsseldorf, Germany. A combination of exhibition, conferences and forums, attract each year numerous visitors from all over the world to the exhibition. aycan Digitalsysteme GmbH, a PACS provider from Würzburg in Germany, will present its multi-modality post-processing workstation

Networking and Knowledge Share Key Components of Pharmaceutical Strategic Patien …

Executives within the patient access and support industry will have the opportunity to network and share ideas with peers at the Pharmaceutical Strategic Patient Access and Support Conference, February 9-10, 2015 in Charlotte, North Carolina, bringing together experts from all corners of the pharmaceutical space. The conference will offer unparalleled workshops and interactive exchange groups to optimize key takeaways and interaction on some of the most top-of-mind issues concerning patient

Amoy Diagnostics, China, Expands List of CE-marked Real-Time PCR Kits for Cancer …

Amoy Diagnostics, who recently appointed MoBiTec GmbH as distributor for Germany, proudly announces the availability of further CE-marked detection kits based on a proprietary real-time PCR technology called “ADx-ARMS” for Cancer Diagnostics. Amoy Diagnostics, headquarted in Xiamen, China, provides state-of-the-art molecular diagnostic products and services to healthcare providers, academic institutions, and pharmaceutical companies. The company has a rich portfolio of tests that focuses on detecting mutations and measuring gene expression in

YEDA and XL-protein sign business collaboration agreement to commercialize PASyl …

FREISING, GERMANY & REHOVOT, ISRAEL, October 21, 2014: Yeda Research and Development Company Ltd., the technology transfer arm of the Weizmann Institute of Science, Israel, and XL-protein GmbH, Germany, a privately owned biopharmaceutical company, have signed a business collaboration agreement to commercialize a PASylated interferon superagonist – PAS-YNSa8 – which has been jointly developed by scientists at the Weizmann Institute and XL-protein. Under this agreement, YEDA acquires the worldwide exclusive rights

The Market for Therapeutic Biologicals is Evolving as Pipeline Candidates Reach …

(Amherst, NH) – Activity in the biological drug sector is set to escalate, as a growing number of drug candidates reach the market and the number of applications requesting marketing authorization for biosimilars increases to a level that will force the FDA to institute new review procedures and expand its resources. The number of new FDA-approved biologicals has averaged between four and five per year over the past decade. This

Medical Device Clinical Trials Conference Back for Eighth Consecutive Year

The most popular conference for clinical research professionals is back with a wide range of new topics and nearly two dozen distinguished presenters speaking on the biggest issues and concerns within the medical device industry. The 8th Annual Medical Device Clinical Trials Conference will be held December 8-9, 2014 in Chicago, Illinois, bringing together directors, vice presidents, and managers of clinical affairs for two days of networking and interactive discussion

Personnel changes in the management board of Berlin Heart GmbH

As of October, 20th 2014 Mr. Sven-René Friedel and Dr. Ares K. Menon are appointed as new members of the management board. In addition to the finance and administration department, Mr. Friedel will be responsible for the departments Research & Development as well as Quality Management & Regulatory Affairs. Dr. Menon will be responsible for the departments Clinical Affairs & Clinical Science, Marketing & Sales, as well as Production. Each

Healthcare Delivery to Developing Countries Using Mobile Technology

How can society best deploy mobile health technology to help save lives and empower communities? On Wednesday, October 22, join human rights advocates and healthcare professionals at the German Center for Research and Innovation (GCRI) in New York for a discussion on new approaches to global health. NEW YORK (October 17, 2014) – The United Nations reports that a child born in the developing world is 33 times more likely to

Venture Capital Funding, Partnership Deal Structures to be Addressed at Medical …

As the medical device industry continues to grow despite increased regulatory hurdles and depleted federal funding, business development professionals face an increasing amount of challenges. At the Medical Device Corporate Strategy and Business Development Conference, senior level executives will gather to discuss the most top of mind trends, best practices, and hurdles, offering attendees a plethora of networking opportunities and implementable ideas. The conference, hosted by Q1 Productions, will be held

National Stress Awareness Day

National Stress Awareness Day is on Wednesday 5th November 2014. Relaxa is offering employee stress & wellbeing health promotion packages starting at £255 on or around this date - incorporating a range of stress & wellbeing activities for your staff. There are 9 cost-effective stress and wellbeing promotion packages available below: 1) Stress Health Promotion Package 1 - £255.00+vat 2) Stress Health Promotion Package 2 - £399.00+vat 3) Stress Health Promotion Package 3

Prostate Cancer Learning Hub Supports Doctors with Online Education

A Prostate Cancer Learning Hub has been launched on website for healthcare professionals (HCPs), epgonline.org. The new interactive resource is designed to support medical professionals in Europe and worldwide in achieving optimum care for individual patients with the often mismanaged disease. Prostate cancer is the third most frequently diagnosed cancer in Europe and the most common cancer among European men.[1] It is thought that 30-40% of patients with prostate cancer

New Accredited Obesity Education Module for Doctors

Almost 3 million deaths a year are attributed to obesity, making it the fifth highest risk factor for death globally. In addition, obesity increases the risk of complications from other co-morbidities such as diabetes (44%), ischaemic heart disease (23%) and many cancers (7-41%).[1] As obesity rates continue to hit the headlines, there is growing pressure on healthcare professionals (HCPs) to stay current on best practice management approaches for their patients. Tackling

Go To Page     111 110 109 108 107 106 105 104 103 102